Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$316,855,200
+$152,180,200 QoQ
Shares Held
1,880,000
+50.4% QoQ
Ownership
1.85%
of shares outstanding
% of Portfolio
7.40%
of 13F equity value
Holder Rank
#11
of 768 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vestal Point Capital, LP holds $635,551,250 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (49.9% of the industry book) .
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,855,200 | 1,880,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $164,675,000 | 1,250,000 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $3,770,700 | 30,000 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $97,923,200 | 710,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $105,408,000 | 800,000 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||